Ginkgo Bioworks – AWS of Synthetic Biology? | SRNG SPAC Merger

Written by Donnie Nguyen

May 16, 2021

Have you been considering investing in Ginkgo Bioworks stock and other SPAC stocks? Watch my video first.

Ginkgo Bioworks is in the process of merging with a SPAC called Soaring Eagle Acquisition Corp. (SRNG). Is Ginkgo the AWS of synthetic biology? In this video, I share my bull case, bear case, and 5-year price target for Ginkgo Bioworks stock.

Find out why I’m bullish on Ginkgo Bioworks stock!


DISCLAIMER: I'm not a financial advisor. These are my opinions and provided "as-is". It is not an offer to buy or sell securities. Read the Terms and Conditions.

So what do you think about Ginkgo Bioworks and other SPAC mergers? Leave me a comment below. Thanks for watching.


I/we have positions in SRNGU

Except for Wolves of Investing, I/we are not receiving any compensation from and do not have any business dealings with any companies whose stocks are discussed in this article/video.

Want to learn the principles that help me to consistently beat the market? Check out my free eBook, 5 Things I Wish I Knew Before Buying My First Stock.


Check out the list of the latest SPAC stocks, updated every week!

Sign up for my Patreon to get my SPAC Trade alerts from my Fidelity All-SPAC portfolio.

Shop for Wolves Of Investing Merch!

Check out our Teespring store.

Notify of
1 Comment
newest most voted
Inline Feedbacks
View all comments
Brant Wassall
Brant Wassall
1 year ago

How do you value the SRNG merger with Ginkgo, considering their purchase of Fungal Platform Technology Company Dutch DNA with combined cash and equity AND Form 12b-25 stating SRNG will be late in filing its form 10-Q because SEC issued recent guidance that warrants should be classified as a liability measured at fair value? Is the transaction fairly valued at $17.5 billion and how does this all affect the Price/Sales ratio, which ideally should be no higher that 20? Many criticize the P/E is over 100. In addition to the $775 million from a private investment in public equity (PIPE),… Read more »

Donnie Nguyen

Donnie Nguyen

Donnie Nguyen is the founder and CEO of Wolves of Investing. He started investing in the stock market in the early 2000s. He follows the teachings of Peter Lynch, Warren Buffett, and other investing legends. When he's not investing or blogging, he loves spending time with his family traveling and experiencing the world.


Follow Donnie on Facebook and Twitter!

5 1 vote
Article Rating

Pin It on Pinterest

Share This